{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:40:30Z","timestamp":1792276830770,"version":"4.4.0"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10388-1","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:02:05Z","timestamp":1792234925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular plasticity in the gastric cancer environment: mechanisms, prognostic significance, and concepts of therapeutic interventions"],"prefix":"10.1007","volume":"45","author":[{"given":"Magdalena","family":"Chmiela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Jaroniek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Rodr\u00edguez","family":"Manzaneque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Balcerczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Brzezi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jele\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wosiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Gonciarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"10388_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. (2026). Global cancer observatory: Cancer today. Lyon, France: International agency for research on cancer.\u00a0https:\/\/gco.iarc.who.int\/today. Accessed (2024)."},{"issue":"6","key":"10388_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/gastro\/goab050","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Zhang, P. S., Rong, Z. Y., & Huang, C. (2021). One stomach, two subtypes of carcinoma-the differences between distal and proximal gastric cancer. Gastroenterology Report, 9(6), 489\u2013504.","journal-title":"Gastroenterology Report"},{"issue":"3","key":"10388_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., et al. (2022). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229\u2013263.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10388_CR4","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun, T. I., Younus, S., & Rahman, M. H. (2024). Gastric cancer-epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat Res Commun., 41, Article 100845.","journal-title":"Cancer Treat Res Commun."},{"key":"10388_CR5","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1038\/s41591-025-03793-6","volume":"31","author":"JY Park","year":"2025","unstructured":"Park, J. Y., Georges, D., Alberts, C. J., et al. (2025). Global lifetime estimates of expected and preventable gastric cancers across 185 countries. Nature Medicine, 31, 3020\u20133027.","journal-title":"Nature Medicine"},{"issue":"5","key":"10388_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020). Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2025. Gut, 69(5), 823\u2013829.","journal-title":"Gut"},{"issue":"10","key":"10388_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick, F., Carneiro, F., Cascinu, S., Fleitas, T., Haustermans, K., Piessen, G., et al. (2022). Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Annals of Oncology, 33(10), 1005\u20131020.","journal-title":"Annals of Oncology"},{"issue":"11","key":"10388_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMsb2515372","volume":"394","author":"JY Park","year":"2026","unstructured":"Park, J. Y., Lee, Y. C., Moayyedi, P., Lansdorp-Vogelaar, I., Camargo, M. C., Tepe\u0161, B., et al. (2026). Helicobacter pylori screen-and-treat programs for gastric cancer prevention - IARC Working Group Report. New England Journal of Medicine, 394(11), 1131\u20131137.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10388_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J., Nicolson, M., et al. (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine, 355(1), 11\u201320.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10388_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","volume":"39","author":"RE Sexton","year":"2020","unstructured":"Sexton, R. E., Al Hallak, M. N., Diab, M., & Azmi, A. S. (2020). Gastric cancer: A comprehensive review of current and future treatment strategies. Cancer and Metastasis Reviews, 39(4), 1179\u20131203.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"2","key":"10388_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.55729\/2000-9666.1304","volume":"14","author":"R Ramachandran","year":"2024","unstructured":"Ramachandran, R., Grantham, T., Parvataneni, S., Budh, D., Gollapalli, S., Reddy, M., et al. (2024). Gastric cancer: Clinical features, screening, diagnosis, treatment, and prevention. Journal of Community Hospital Internal Medicine Perspectives, 14(2), 49\u201357.","journal-title":"Journal of Community Hospital Internal Medicine Perspectives"},{"key":"10388_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan, W. L., He, Y., & Xu, R. H. (2023). Gastric cancer treatment: Recent progress and future perspectives. Journal of Hematology & Oncology, 16, 57.","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10388_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114580","volume":"449","author":"S Biswas","year":"2025","unstructured":"Biswas, S., Kanodia, R., Seervi, S., Kaur, R., Shukla, S., Singh, S., et al. (2025). Portrayal of the complex molecular landscape of multidrug resistance in gastric cancer: Unveiling the potential targets. Experimental Cell Research, 449(1), Article 114580.","journal-title":"Experimental Cell Research"},{"key":"10388_CR14","doi-asserted-by":"publisher","first-page":"12385","DOI":"10.2147\/CMAR.S274599","volume":"12","author":"WJ Huang","year":"2020","unstructured":"Huang, W. J., Ruan, S., Wen, F., Lu, X. N., Gu, S. P., Chen, X. X., et al. (2020). Multidrug resistance of gastric cancer: The Mechanisms and Chinese medicine reversal agents. Cancer Manag Res., 12, 12385\u201312394.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"10388_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41420-025-02429-5","volume":"11","author":"Q Yin","year":"2025","unstructured":"Yin, Q., Zhang, Y., Xie, X., Hou, M., Chen, X., & Ding, J. (2025). Navigating the future of gastric cancer treatment: A review on the impact of antibody-drug conjugates. Cell Death Discov., 11(1), 144.","journal-title":"Cell Death Discov."},{"issue":"1","key":"10388_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01075-y","volume":"31","author":"D Luo","year":"2025","unstructured":"Luo, D., Liu, Y., Lu, Z., & Huang, L. (2025). Targeted therapy and immunotherapy for gastric cancer: Rational strategies, novel advancements, challenges, and future perspectives. Molecular Medicine, 31(1), Article 52.","journal-title":"Molecular Medicine"},{"issue":"8","key":"10388_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1634\/theoncologist.2019-0294","volume":"24","author":"DY Oh","year":"2019","unstructured":"Oh, D. Y., Lee, K. W., Han, S. W., Kim, J. W., Shin, J. W., Jo, S. J., et al. (2019). A first-in-human phase I study of GC1118, a novel anti-epidermal growth factor receptor antibody, in patients with advanced solid tumors. The Oncologist, 24(8), 1037-e636.","journal-title":"The Oncologist"},{"key":"10388_CR18","doi-asserted-by":"crossref","unstructured":"Yang M, Lin W, Huang J, Mannucci A, Luo H. Novel immunotherapeutic approaches in gastric cancer. Precis Clin Med. 2024;7(4):pbae020.","DOI":"10.1093\/pcmedi\/pbae020"},{"issue":"10002","key":"10388_CR19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","volume":"386","author":"M Zeng","year":"2015","unstructured":"Zeng, M., Mao, X. H., Li, J. X., Tong, W. D., Wang, B., Zhang, Y. J., et al. (2015). Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: A randomized, double-blind, placebo-controlled, phase 3 trial. Lancet, 386(10002), 1457\u201364.","journal-title":"Lancet"},{"issue":"6","key":"10388_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060571","volume":"11","author":"MA Subhan","year":"2021","unstructured":"Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021). Recent advances in tumor targeting via EPR effect for cancer treatment. Journal of Personalized Medicine, 11(6), Article 571.","journal-title":"Journal of Personalized Medicine"},{"key":"10388_CR21","first-page":"251","volume":"3","author":"B Hu","year":"2012","unstructured":"Hu, B., El, H. N., Sittler, S., Lammert, N., Barnes, R., & Meloni-Ehrig, A. (2012). Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol., 3, 251\u2013261.","journal-title":"J Gastrointest Oncol."},{"key":"10388_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12328-020-01295-1","volume":"14","author":"A Forma","year":"2021","unstructured":"Forma, A., Tyczynska, M., Kedzierawski, P., Gietka, K., & Sitarz, M. (2021). Gastric carcinogenesis: A comprehensive review of the angiogenic pathways. Clinical Journal of Gastroenterology, 14, 14\u201325.","journal-title":"Clinical Journal of Gastroenterology"},{"key":"10388_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2025.102298","volume":"63","author":"SO Dima","year":"2025","unstructured":"Dima, S. O., Sorop, A., Kitahara, S., Setia, N., Chivu-Economescu, M., Matei, L., et al. (2025). A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment. Surgical Oncology, 63, Article 102298.","journal-title":"Surgical Oncology"},{"key":"10388_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa, P., & Piazuelo, M. B. (2012). The gastric precancerous cascade. Journal of Digestive Diseases, 13, 2\u20139.","journal-title":"Journal of Digestive Diseases"},{"key":"10388_CR25","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.ejca.2009.04.007","volume":"45","author":"M Raica","year":"2009","unstructured":"Raica, M., Cimpean, A. M., & Ribatti, D. (2009). Angiogenesis in pre-malignant conditions. European Journal of Cancer, 45, 1924\u201334.","journal-title":"European Journal of Cancer"},{"key":"10388_CR26","doi-asserted-by":"publisher","first-page":"8192","DOI":"10.3748\/wjg.v19.i45.8192","volume":"19","author":"KE Lee","year":"2013","unstructured":"Lee, K. E., Khoi, P. N., Xia, Y., Park, J. S., Joo, Y. E., Kim, K. K., et al. (2013). Helicobacter pylori and interleukin-8 in gastric cancer. World Journal of Gastroenterology, 19, 8192\u20138202.","journal-title":"World Journal of Gastroenterology"},{"key":"10388_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115267","volume":"218","author":"C Meier","year":"2025","unstructured":"Meier, C., & Brieger, A. (2025). The role of IL-8 in cancer development and its impact on immunotherapy resistance. European Journal of Cancer, 218, Article 115267.","journal-title":"European Journal of Cancer"},{"key":"10388_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/jso.23110","volume":"106","author":"H Wu","year":"2012","unstructured":"Wu, H., Xu, J. B., He, Y. L., Peng, J. J., Zhang, X. H., Chen, C. Q., et al. (2012). Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. Journal of Surgical Oncology, 106, 462\u20138.","journal-title":"Journal of Surgical Oncology"},{"key":"10388_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41568-023-00591-5","volume":"23","author":"Q Zeng","year":"2023","unstructured":"Zeng, Q., Mousa, M., Nadukkandy, A. S., Franssens, L., Alnaqbi, H., Alshamsi, F. Y., et al. (2023). Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nature Reviews. Cancer, 23, 544\u2013564.","journal-title":"Nature Reviews. Cancer"},{"issue":"8","key":"10388_CR30","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.7150\/thno.71833","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y., Hu, X., Lin, R., Zhou, G., Zhao, L., Zhao, D., et al. (2022). Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer. Theranostics, 12(8), 3818\u20133833.","journal-title":"Theranostics"},{"key":"10388_CR31","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3390\/cancers14112711","volume":"14","author":"CU Metin","year":"2022","unstructured":"Metin, C. U., & Ozcan, G. (2022). The HIF-1\u03b1 as a potent inducer of the hallmarks in gastric cancer. Cancers (Basel)., 14, 2711.","journal-title":"Cancers (Basel)."},{"key":"10388_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1553477","volume":"16","author":"S Yang","year":"2025","unstructured":"Yang, S., Jiang, Y., & Yang, Z. (2025). Hypoxia-associated genes as predictors of outcomes in gastric cancer: A genomic approach. Frontiers in Immunology, 16, Article 1553477.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10388_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe\u2019er, J., Trent, J. M., et al. (1999). Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. American Journal of Pathology, 155(3), 739\u2013752.","journal-title":"American Journal of Pathology"},{"key":"10388_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107805","volume":"223","author":"L Treps","year":"2021","unstructured":"Treps, L., Faure, S., & Clere, N. (2021). Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target. Pharmacology & Therapeutics, 223, Article 107805.","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10388_CR35","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","volume":"181","author":"RE Seftor","year":"2012","unstructured":"Seftor, R. E., Hess, A. R., Seftor, E. A., Kirschmann, D. A., Hardy, K. M., Margaryan, N. V., et al. (2012). Tumor cell vasculogenic mimicry: From controversy to therapeutic promise. American Journal of Pathology, 181(4), 1115\u201325.","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10388_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo, Q., Wang, J., Zhao, W., Peng, Z., Liu, X., Li, B., et al. (2020). Vasculogenic mimicry in carcinogenesis and clinical applications. Journal of Hematology & Oncology, 13(1), Article 19.","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10388_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40265-7","volume":"9","author":"HS Kim","year":"2019","unstructured":"Kim, H. S., Won, Y. J., Shim, J. H., Kim, H. J., Kim, J., Hong, H. N., et al. (2019). Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma. Scientific Reports, 9(1), Article 3414.","journal-title":"Scientific Reports"},{"issue":"1","key":"10388_CR38","first-page":"1","volume":"2","author":"A Chaudhary","year":"2019","unstructured":"Chaudhary, A., Singh, N., Vipin Kumar, G., & Verma, M. (2019). Vasculogenic mimicry and its role in cancer. Am J Pharmacol., 2(1), 1\u20136.","journal-title":"Am J Pharmacol."},{"issue":"48","key":"10388_CR39","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.3748\/wjg.v27.i48.8262","volume":"27","author":"MA Senchukova","year":"2021","unstructured":"Senchukova, M. A. (2021). Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer. World Journal of Gastroenterology, 27(48), 8262\u20138282.","journal-title":"World Journal of Gastroenterology"},{"issue":"10","key":"10388_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17101675","volume":"17","author":"L Larrea Murillo","year":"2025","unstructured":"Larrea Murillo, L., Green, M., Mahon, N., Saiani, A., & Tsigkou, O. (2025). Modelling cancer pathophysiology: Mechanisms and changes in the extracellular matrix during cancer initiation and early tumour growth. Cancers, 17(10), Article 1675.","journal-title":"Cancers"},{"issue":"3","key":"10388_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley, A. C., & Griffioen, A. W. (2023). Pathological angiogenesis: Mechanisms and therapeutic strategies. Angiogenesis, 26(3), 313\u2013347.","journal-title":"Angiogenesis"},{"issue":"5","key":"10388_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/modpathol.2010.231","volume":"24","author":"S IeM","year":"2011","unstructured":"IeM, S. (2011). Trophoblastic vasculogenic mimicry in gestational choriocarcinoma. Modern Pathology, 24(5), 646\u201352.","journal-title":"Modern Pathology"},{"issue":"6","key":"10388_CR43","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/biom13060886","volume":"13","author":"A Biagioni","year":"2023","unstructured":"Biagioni, A., Peri, S., Versienti, G., Fiorillo, C., Becatti, M., Magnelli, L., et al. (2023). Gastric cancer vascularization and the contribution of reactive oxygen species. Biomolecules, 13(6), 886.","journal-title":"Biomolecules"},{"key":"10388_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2025.100153","volume":"15","author":"C Guan","year":"2025","unstructured":"Guan, C., Hao, L., Gong, B., & Zheng, L. (2025). The mechanisms of action and targeting potential of vasculogenic mimicry in breast cancer metastasis. Adv Cancer Biol Metastasis., 15, Article 100153.","journal-title":"Adv Cancer Biol Metastasis."},{"issue":"8","key":"10388_CR45","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/cas.14521","volume":"111","author":"Y Oya","year":"2020","unstructured":"Oya, Y., Hayakawa, Y., & Koike, K. (2020). Tumor microenvironment in gastric cancers. Cancer Science, 111(8), 2696\u20132707.","journal-title":"Cancer Science"},{"issue":"13","key":"10388_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133160","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang, X., Wang, X., Xu, M., & Sheng, W. (2021). Effects of CAF-derived microRNA on tumor biology and clinical applications. Cancers, 13(13), Article 3160.","journal-title":"Cancers"},{"issue":"7","key":"10388_CR47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41556-019-0339-9","volume":"21","author":"M Sigal","year":"2019","unstructured":"Sigal, M., Rein\u00e9s, M. D. M., M\u00fcllerke, S., Fischer, C., Kapalczynska, M., Berger, H., et al. (2019). R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach. Nature Cell Biology, 21(7), 812\u2013823.","journal-title":"Nature Cell Biology"},{"issue":"7","key":"10388_CR48","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang, D., Liu, J., Qian, H., & Zhuang, Q. (2023). Cancer-associated fibroblasts: From basic science to anticancer therapy. Experimental and Molecular Medicine, 55(7), 1322\u20131332.","journal-title":"Experimental and Molecular Medicine"},{"issue":"3","key":"10388_CR49","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/j.gastro.2021.11.037","volume":"162","author":"H Kobayashi","year":"2022","unstructured":"Kobayashi, H., Gieniec, K. A., Lannagan, T. R. M., Wang, T., Asai, N., Mizutani, Y., et al. (2022). The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology, 162(3), 890\u2013906.","journal-title":"Gastroenterology"},{"key":"10388_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155962","volume":"134","author":"H Wang","year":"2024","unstructured":"Wang, H., Ding, Q., Zhou, H., Huang, C., Liu, G., Zhao, X., et al. (2024). Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2\/FGFR1 signaling pathway. Phytomedicine, 134, Article 155962.","journal-title":"Phytomedicine"},{"issue":"2","key":"10388_CR51","first-page":"1185","volume":"40","author":"X Ding","year":"2018","unstructured":"Ding, X., Xi, W., Ji, J., Cai, Q., Jiang, J., Shi, M., et al. (2018). HGF derived from cancer associated fibroblasts promotes vascularization in gastric cancer via PI3K\/AKT and ERK1\/2 signaling. Oncology Reports, 40(2), 1185\u20131195.","journal-title":"Oncology Reports"},{"issue":"1","key":"10388_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2424490","volume":"25","author":"X Duan","year":"2024","unstructured":"Duan, X., Yu, X., & Gan, J. (2024). Extracellular vesicle-packaged miR-4253 secreted by cancer-associated fibroblasts facilitates cell proliferation in gastric cancer by inducing macrophage M2 polarization. Cancer Biology & Therapy, 25(1), Article 2424490.","journal-title":"Cancer Biology & Therapy"},{"issue":"1","key":"10388_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02499-8","volume":"41","author":"S Qiu","year":"2022","unstructured":"Qiu, S., Xie, L., Lu, C., Gu, C., Xia, Y., Lv, J., et al. (2022). Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis. Journal of Experimental & Clinical Cancer Research, 41(1), Article 296.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10388_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bjc.6602901","volume":"94","author":"L Bingle","year":"2006","unstructured":"Bingle, L., Lewis, C. E., Corke, K. P., Reed, M. W., & Brown, N. J. (2006). Macrophages promote angiogenesis in human breast tumor spheroids in vivo. British Journal of Cancer, 94, 101\u20137.","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10388_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.clinre.2015.09.005","volume":"40","author":"JY Park","year":"2016","unstructured":"Park, J. Y., Sung, J. Y., Lee, J., Park, Y. K., Kim, Y. W., Kim, G. Y., et al. (2016). Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer. Clinics and Research in Hepatology and Gastroenterology, 40(3), 357\u2013365.","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"9","key":"10388_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092106","volume":"20","author":"G Sammarco","year":"2019","unstructured":"Sammarco, G., Varricchi, G., Ferraro, V., Ammendola, M., De Fazio, M., Altomare, D. F., et al. (2019). Mast cells, angiogenesis and lymphangiogenesis in human gastric cancer. International Journal of Molecular Sciences, 20(9), Article 2106.","journal-title":"International Journal of Molecular Sciences"},{"key":"10388_CR57","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3748\/wjg.v13.i25.3466","volume":"13","author":"XY Mao","year":"2007","unstructured":"Mao, X. Y., Wang, X. G., Lv, X. J., Xu, L., & Han, C. B. (2007). COX-2 expression in gastric cancer and its relationship with angiogenesis using tissue microarray. World Journal of Gastroenterology, 13, 3466\u201371.","journal-title":"World Journal of Gastroenterology"},{"issue":"Suppl 2","key":"10388_CR58","doi-asserted-by":"publisher","first-page":"S289","DOI":"10.1016\/s0753-3322(05)80048-4","volume":"59","author":"YL Wu","year":"2005","unstructured":"Wu, Y. L., Fu, S. L., Zhang, Y. P., Qiao, M. M., & Chen, Y. (2005). Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts. Biomedicine & Pharmacotherapy, 59(Suppl 2), S289-92. https:\/\/doi.org\/10.1016\/s0753-3322(05)80048-4","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10388_CR59","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3748\/wjg.v10.i13.1971","volume":"10","author":"SL Fu","year":"2004","unstructured":"Fu, S. L., Wu, Y. L., Zhang, Y. P., Qiao, M. M., & Chen, Y. (2004). Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World Journal of Gastroenterology, 10, 1971\u20134.","journal-title":"World Journal of Gastroenterology"},{"key":"10388_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/jso.20372","volume":"94","author":"CN Chen","year":"2006","unstructured":"Chen, C. N., Hsieh, F. J., Cheng, Y. M., Chang, K. J., & Lee, P. H. (2006). Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. Journal of Surgical Oncology, 94, 226\u201333.","journal-title":"Journal of Surgical Oncology"},{"issue":"30","key":"10388_CR61","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1038\/s41388-018-0250-z","volume":"37","author":"J Zhao","year":"2018","unstructured":"Zhao, J., Du, P., Cui, P., Qin, Y., Hu, C., Wu, J., et al. (2018). LncRNA PVT1 promotes angiogenesis via activating the STAT3\/VEGFA axis in gastric cancer. Oncogene, 37(30), 4094\u20134109.","journal-title":"Oncogene"},{"key":"10388_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2019.04.029","volume":"704","author":"E Tang","year":"2019","unstructured":"Tang, E., Wang, Y., Liu, T., & Yan, B. (2019). Gastrin promotes angiogenesis by activating HIF-1\u03b1\/\u03b2-catenin\/VEGF signaling in gastric cancer. Gene, 704, 42\u201348.","journal-title":"Gene"},{"issue":"18","key":"10388_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813770","volume":"24","author":"G Morales-Guadarrama","year":"2023","unstructured":"Morales-Guadarrama, G., M\u00e9ndez-P\u00e9rez, E. A., Garc\u00eda-Quiroz, J., Avila, E., Ibarra-S\u00e1nchez, M. J., Esparza-L\u00f3pez, J., et al. (2023). The inhibition of the FGFR\/PI3K\/Akt axis by AZD4547 disrupts the proangiogenic microenvironment and vasculogenic mimicry arising from the interplay between endothelial and triple-negative breast cancer cells. International Journal of Molecular Sciences, 24(18), Article 13770.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10388_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061674","volume":"12","author":"S Boichuk","year":"2020","unstructured":"Boichuk, S., Galembikova, A., Mikheeva, E., Bikinieva, F., Aukhadieva, A., Dunaev, P., et al. (2020). Inhibition of FGF2-mediated signaling in GIST-promising approach for overcoming resistance to Imatinib. Cancers, 12(6), Article 1674.","journal-title":"Cancers"},{"issue":"17","key":"10388_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173103","volume":"16","author":"S Boichuk","year":"2024","unstructured":"Boichuk, S., Dunaev, P., Galembikova, A., & Valeeva, E. (2024). Fibroblast growth factor 2 (FGF2) activates vascular endothelial growth factor (VEGF) signaling in gastrointestinal stromal tumors (GIST): An autocrine mechanism contributing to Imatinib Mesylate (IM) resistance. Cancers, 16(17), Article 3103.","journal-title":"Cancers"},{"issue":"13","key":"10388_CR66","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.18632\/oncotarget.3416","volume":"6","author":"L Wang","year":"2015","unstructured":"Wang, L., Lin, L., Chen, X., Sun, L., Liao, Y., Huang, N., et al. (2015). Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1\/2. Oncotarget, 6(13), 11492\u2013506.","journal-title":"Oncotarget"},{"issue":"29","key":"10388_CR67","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.3748\/wjg.v22.i29.6629","volume":"22","author":"ZZ Wu","year":"2016","unstructured":"Wu, Z. Z., Chen, L. S., Zhou, R., Bin, J. P., Liao, Y. L., & Liao, W. J. (2016). Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis. World Journal of Gastroenterology, 22(29), 6629\u201337.","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10388_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02494-6","volume":"7","author":"J Sun","year":"2017","unstructured":"Sun, J., Sun, B., Sun, R., Zhu, D., Zhao, X., Zhang, Y., et al. (2017). HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma. Scientific Reports, 7(1), Article 2229.","journal-title":"Scientific Reports"},{"issue":"7","key":"10388_CR69","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.7150\/jca.92192","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Sun, B., Lin, Y., Deng, H., Wang, X., Xu, C., et al. (2024). Lysyl oxidase promotes the formation of vasculogenic mimicry in gastric cancer through PDGF-PDGFR pathway. Journal of Cancer, 15(7), 1816\u20131825.","journal-title":"Journal of Cancer"},{"key":"10388_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.103185","volume":"98","author":"Y Fan","year":"2025","unstructured":"Fan, Y., Liu, Y., Jiang, N., Qian, S., Huang, X., Wu, J., et al. (2025). IL-8\/CXCR2 mediates resistance to apatinib through PI3K\/AKT and vasculogenic mimicry in gastric cancer cells. Tissue & cell., 98, Article 103185.","journal-title":"Tissue & cell."},{"key":"10388_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-1009-z","volume":"14","author":"DM Ma","year":"2016","unstructured":"Ma, D. M., Luo, D. X., & Zhang, J. (2016). SDF-1\/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells. World Journal of Surgical Oncology, 14, Article 256.","journal-title":"World Journal of Surgical Oncology"},{"key":"10388_CR72","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/cbin.10794","volume":"41","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Xu, F., Shi, Y., Chen, Y. W., Wang, H. P., Yu, X., & Li, Y. (2017). C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2\/STAT3. Cell Biology International, 41, 854\u2013862.","journal-title":"Cell Biology International"},{"issue":"2","key":"10388_CR73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jss.2007.08.014","volume":"148","author":"J Ma","year":"2008","unstructured":"Ma, J., Sawai, H., Matsuo, Y., Ochi, N., Yasuda, A., Takahashi, H., et al. (2008). Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines. Journal of Surgical Research, 148(2), 197\u2013204.","journal-title":"Journal of Surgical Research"},{"issue":"10","key":"10388_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101551","volume":"13","author":"T Matsuoka","year":"2023","unstructured":"Matsuoka, T., & Yashiro, M. (2023). The role of the transforming growth factor-\u03b2 signaling pathway in gastrointestinal cancers. Biomolecules, 13(10), Article 1551.","journal-title":"Biomolecules"},{"issue":"43","key":"10388_CR75","doi-asserted-by":"publisher","first-page":"70152","DOI":"10.18632\/oncotarget.12161","volume":"7","author":"W Gong","year":"2016","unstructured":"Gong, W., Sun, B., Zhao, X., Zhang, D., Sun, J., Liu, T., et al. (2016). Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2\/3 pathway. Oncotarget, 7(43), 70152\u201370167. https:\/\/doi.org\/10.18632\/oncotarget.12161","journal-title":"Oncotarget"},{"issue":"3","key":"10388_CR76","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1755-148X.2008.00463.x","volume":"21","author":"LM Postovit","year":"2008","unstructured":"Postovit, L. M., Margaryan, N. V., Seftor, E. A., & Hendrix, M. J. C. (2008). Role of nodal signaling and the microenvironment underlying melanoma plasticity. Pigment Cell & Melanoma Research, 21(3), 348\u2013357. https:\/\/doi.org\/10.1111\/j.1755-148X.2008.00463.x","journal-title":"Pigment Cell & Melanoma Research"},{"issue":"3","key":"10388_CR77","first-page":"3031","volume":"18","author":"HS Kim","year":"2019","unstructured":"Kim, H. S., Won, Y. J., Shim, J. H., Kim, H. J., Kim, B. S., & Hong, H. N. (2019). Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncology Letters, 18(3), 3031\u20133038.","journal-title":"Oncology Letters"},{"issue":"17","key":"10388_CR78","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1080\/15384101.2023.2231740","volume":"22","author":"C Wu","year":"2023","unstructured":"Wu, C., Li, D., Cheng, X., Gu, H., Qian, Y., & Feng, L. (2023). Downregulation of cancer-associated fibroblast exosome-derived miR-29b-1-5p restrains vasculogenic mimicry and apoptosis while accelerating migration and invasion of gastric cancer cells via immunoglobulin domain-containing 1\/zonula occluden-1 axis. Cell Cycle, 22(17), 1807\u20131826.","journal-title":"Cell Cycle"},{"key":"10388_CR79","doi-asserted-by":"crossref","unstructured":"Joo YE, Sohn YH, Joo SY, Lee WS, Min SW, Park CH, et all. he role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer. Korean J Intern Med. 2002;17(4):211\u20139.","DOI":"10.3904\/kjim.2002.17.4.211"},{"key":"10388_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1349-7006.2003.tb01350.x","volume":"94","author":"T Kaneko","year":"2003","unstructured":"Kaneko, T., Konno, H., Baba, M., Tanaka, T., & Nakamura, S. (2003). Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Science, 94, 43\u20139.","journal-title":"Cancer Science"},{"key":"10388_CR81","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbrc.2018.05.109","volume":"501","author":"ZH Wu","year":"2018","unstructured":"Wu, Z. H., Lin, C., Liu, C. C., Jiang, W. W., Huang, M. Z., Liu, X., et al. (2018). MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN\/AKT\/mTOR pathway. Biochemical and Biophysical Research Communications, 501, 1068\u20131073.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10388_CR82","doi-asserted-by":"publisher","first-page":"33269","DOI":"10.18632\/oncotarget.5037","volume":"6","author":"SH Lee","year":"2015","unstructured":"Lee, S. H., Jung, Y. D., Choi, Y. S., & Lee, Y. M. (2015). Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget, 6, 33269\u201378.","journal-title":"Oncotarget"},{"issue":"5","key":"10388_CR83","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3892\/or.2015.3878","volume":"33","author":"K Hara","year":"2015","unstructured":"Hara, K., Fukui, H., Sun, C., Kitayama, Y., Eda, H., Yamasaki, T., et al. (2015). Effect of REG I\u03b1 protein on angiogenesis in gastric cancer tissues. Oncology Reports, 33(5), 2183\u20139.","journal-title":"Oncology Reports"},{"key":"10388_CR84","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/j.1572-0241.1999.01158.x","volume":"94","author":"N Koide","year":"1999","unstructured":"Koide, N., Nishio, A., Igarashi, J., Kajikawa, S., Adachi, W., & Amano, J. (1999). Alpha-fetoprotein-producing gastric cancer: Histochemical analysis of cell proliferation, apoptosis, and angiogenesis. American Journal of Gastroenterology, 94, 1658\u201363.","journal-title":"American Journal of Gastroenterology"},{"key":"10388_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152454","volume":"215","author":"E Chen","year":"2019","unstructured":"Chen, E., Tang, C., Peng, K., Cheng, X., Wei, Y., & Liu, T. (2019). ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression. Pathology, Research and Practice, 215, Article 152454.","journal-title":"Pathology, Research and Practice"},{"issue":"5","key":"10388_CR86","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.bbadis.2015.02.005","volume":"1852","author":"M Zang","year":"2015","unstructured":"Zang, M., Zhang, Y., Zhang, B., Hu, L., Li, J., Fan, Z., et al. (2015). CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling. Biochimica et Biophysica Acta, 1852(5), 1020\u20138.","journal-title":"Biochimica et Biophysica Acta"},{"key":"10388_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3858\/emm.2012.44.1.025","volume":"44","author":"S De Falco","year":"2012","unstructured":"De Falco, S. (2012). The discovery of placenta growth factor and its biological activity. Experimental and Molecular Medicine, 44, 1\u20139.","journal-title":"Experimental and Molecular Medicine"},{"issue":"9","key":"10388_CR88","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/01.meg.0000230086.83792.56","volume":"18","author":"GH Lee","year":"2006","unstructured":"Lee, G. H., Joo, Y. E., Koh, Y. S., Chung, I. J., Park, Y. K., Lee, J. H., et al. (2006). Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. European Journal of Gastroenterology & Hepatology, 18(9), 957\u201363.","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"8","key":"10388_CR89","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1158\/0008-5472.CAN-08-3045","volume":"69","author":"Q Li","year":"2009","unstructured":"Li, Q., Zhang, N., Jia, Z., Le, X., Dai, B., Wei, D., et al. (2009). Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Research, 69(8), 3501\u20139.","journal-title":"Cancer Research"},{"key":"10388_CR90","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017799","volume":"98","author":"X Tao","year":"2019","unstructured":"Tao, X., Cheng, L., Li, Y., Ci, H., Xu, J., Wu, S., & Tao, Y. (2019). Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer. Medicine (Baltimore), 98, Article e17799.","journal-title":"Medicine (Baltimore)"},{"key":"10388_CR91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2017.02.035","volume":"395","author":"Y Li","year":"2017","unstructured":"Li, Y., Wu, Z., Yuan, J., Sun, L., Lin, L., Huang, N., et al. (2017). Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Letters, 395, 31\u201344.","journal-title":"Cancer Letters"},{"issue":"19","key":"10388_CR92","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/jnci\/djh267","volume":"96","author":"DWJ van der Schaft","year":"2004","unstructured":"van der Schaft, D. W. J., Seftor, R. E. B., Seftor, E. A., Hess, A. R., Gruman, L. M., Kirschmann, D. A., et al. (2004). Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. Journal of the National Cancer Institute, 96(19), 1473\u20131477. https:\/\/doi.org\/10.1093\/jnci\/djh267","journal-title":"Journal of the National Cancer Institute"},{"key":"10388_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1611038","volume":"29","author":"L Shen","year":"2023","unstructured":"Shen, L., Chen, Y. L., Huang, C. C., Shyu, Y. C., Seftor, R. E. B., Seftor, E. A., et al. (2023). CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1. Pathology & Oncology Research, 29, Article 1611038. https:\/\/doi.org\/10.3389\/pore.2023.1611038","journal-title":"Pathology & Oncology Research"},{"key":"10388_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-026-03515-w","author":"CJ Yen","year":"2026","unstructured":"Yen, C. J., Chen, M. H., Chen, Y. Y., Bai, L. Y., Chen, J. S., Hsieh, J. C. H., et al. (2026). Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: A phase IIa trial. British Journal of Cancer. https:\/\/doi.org\/10.1038\/s41416-026-03515-w","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10388_CR95","first-page":"4726","volume":"16","author":"AA Vartanian","year":"2009","unstructured":"Vartanian, A. A., Stepanova, E. V., Gutorov, S. L., Solomko, ESh., Grigorieva, I. N., Sokolova, I. N., et al. (2009). Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. The Canadian Journal of Urology, 16(4), 4726\u201332.","journal-title":"The Canadian Journal of Urology"},{"issue":"2","key":"10388_CR96","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2006.12.036","volume":"254","author":"S Zhang","year":"2007","unstructured":"Zhang, S., Zhang, D., & Sun, B. (2007). Vasculogenic mimicry: Current status and future prospects. Cancer Letters, 254(2), 157\u201364.","journal-title":"Cancer Letters"},{"issue":"6","key":"10388_CR97","first-page":"1609","volume":"25","author":"B Sun","year":"2004","unstructured":"Sun, B., Zhang, S., Zhao, X., Zhang, W., & Hao, X. (2004). Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. International Journal of Oncology, 25(6), 1609\u20131614.","journal-title":"International Journal of Oncology"},{"issue":"4","key":"10388_CR98","first-page":"693","volume":"16","author":"B Sun","year":"2006","unstructured":"Sun, B., Zhang, S., Zhang, D., Du, J., Guo, H., Zhao, X., et al. (2006). Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncology Reports, 16(4), 693\u2013698.","journal-title":"Oncology Reports"},{"issue":"6","key":"10388_CR99","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc1092","volume":"3","author":"MJ Hendrix","year":"2003","unstructured":"Hendrix, M. J., Seftor, E. A., Hess, A. R., & Seftor, R. E. (2003). Vasculogenic mimicry and tumor-cell plasticity: Lessons from melanoma. Nature Reviews Cancer, 3(6), 411\u201321.","journal-title":"Nature Reviews Cancer"},{"key":"10388_CR100","unstructured":"IARC. IARC monographs on the evaluation of carcinogenic risks to humans. 2009;100B:1\u2013441. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/iarc-Monographs-On-The-Identification-Of-Carcinogenic -Hazards-To-Humans\/Biologic-Agents-2012."},{"issue":"61","key":"10388_CR101","first-page":"1","volume":"1994","author":"IARC","year":"1994","unstructured":"IARC. (1994). Working Group on the Evaluation of Carcinogenic Risk to Humans. IARC Monogr Eval Carcinog Riska Hum., 1994(61), 1\u2013241.","journal-title":"IARC Monogr Eval Carcinog Riska Hum."},{"issue":"4","key":"10388_CR102","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v16.i4.111432","volume":"16","author":"JMC Costa","year":"2025","unstructured":"Costa, J. M. C., Aguiar, C. E. O., Oliveira, M. M. G. L., Cenci Dietrich, V., Lima, P. H. M., Freire, J. P. C., et al. (2025). Update on the pathogenesis and clinical management of Helicobacter pylori gastric infection and associated diseases. World Journal of Gastrointestinal Pathophysiology, 16(4), Article 111432.","journal-title":"World Journal of Gastrointestinal Pathophysiology"},{"key":"10388_CR103","first-page":"53","volume":"421","author":"K Rudnicka","year":"2019","unstructured":"Rudnicka, K., Backert, S., & Chmiela, M. (2019). Genetic polymorphisms in inflammatory and other regulators in gastric cancer: Risks and clinical consequences. Current Topics in Microbiology and Immunology, 421, 53\u201376.","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10388_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220636","volume":"14","author":"W Gonciarz","year":"2019","unstructured":"Gonciarz, W., Krupa, A., Hinc, K., Obuchowski, M., Moran, A., Gajewski, A., et al. (2019). The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS ONE, 14, Article e0220636.","journal-title":"PLoS ONE"},{"key":"10388_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1006\/cimm.2000.1654","volume":"202","author":"B Paziak-Domanska","year":"2000","unstructured":"Paziak-Domanska, B., Chmiela, M., Jarosinska, A., & Rudnicka, W. (2000). Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Cellular Immunology, 202, 136\u2013139.","journal-title":"Cellular Immunology"},{"key":"10388_CR106","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1462-5822.2007.00906.x","volume":"9","author":"LA Allen","year":"2007","unstructured":"Allen, L. A. (2007). Phagocytosis and persistence of Helicobacter pylori. Cellular Microbiology, 9, 817\u2013829.","journal-title":"Cellular Microbiology"},{"key":"10388_CR107","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1753425913518225","volume":"21","author":"K Rudnicka","year":"2015","unstructured":"Rudnicka, K., Miszczyk, E., Matusiak, A., Walencka, M., Moran, A. P., Rudnicka, W., et al. (2015). Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity. Innate Immunity, 21, 127\u2013139.","journal-title":"Innate Immunity"},{"key":"10388_CR108","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.virol.2017.10.017","volume":"513","author":"PG Cantalupo","year":"2018","unstructured":"Cantalupo, P. G., Katz, J. P., & Pipas, J. M. (2018). Viral sequences in human cancer. Virology, 513, 208\u2013216.","journal-title":"Virology"},{"key":"10388_CR109","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin, N., Antunes, C. A., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021). Microbiome and cancer. Cancer Cell, 39, 1317\u20131341.","journal-title":"Cancer Cell"},{"key":"10388_CR110","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3389\/fmicb.2016.01357","volume":"7","author":"K Dabrowska","year":"2016","unstructured":"Dabrowska, K., & Witkiewicz, W. (2016). Correlations of host genetics and gut microbiome composition. Frontiers in Microbiology, 7, 1357.","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10388_CR111","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Abele, G., Miggiano, D., Gasbarrini, A., & Mele, M. C. (2019). What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms., 7(1), 14.","journal-title":"Microorganisms."},{"issue":"6","key":"10388_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066019","volume":"8","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G. D., et al. (2013). Archea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS ONE, 8(6), Article e66019.","journal-title":"PLoS ONE"},{"issue":"2","key":"10388_CR113","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin, M., Warren, R. L., Freeman, J. D., Freeman, J. D., Dreolini, L., Krzywinski, M., et al. (2012). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research, 22(2), 299\u2013306.","journal-title":"Genome Research"},{"issue":"2","key":"10388_CR114","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., et al. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe, 14(2), 207\u2013215.","journal-title":"Cell Host & Microbe"},{"issue":"9","key":"10388_CR115","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1158\/1055-9965.EPI-09-0334","volume":"18","author":"M Tezal","year":"2009","unstructured":"Tezal, M., Sullivan, M. A., Hyland, A., Marshall, J. R., Stoler, D., Reid, M. E., et al. (2009). Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers., 18(9), 2406\u20132412.","journal-title":"Cancer Epidemiol Biomarkers."},{"issue":"8","key":"10388_CR116","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/jnci\/djx278","volume":"110","author":"DS Michaud","year":"2018","unstructured":"Michaud, D. S., Lu, J., Peacock-Villada, A. Y., Barber, J. R., Joshu, C. E., Prizment, A. E., et al. (2018). Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study. Journal of the National Cancer Institute, 110(8), 843\u2013854.","journal-title":"Journal of the National Cancer Institute"},{"key":"10388_CR117","doi-asserted-by":"publisher","first-page":"97273","DOI":"10.18632\/oncotarget.21921","volume":"8","author":"PK Mukherjee","year":"2017","unstructured":"Mukherjee, P. K., Wang, H., Retuerto, M., Zhang, H., Burkey, B., Ghannoum, M. A., et al. (2017). Bacteriome and mycobiome associations in oral tongue cancer. Oncotarget, 8, 97273\u201397289.","journal-title":"Oncotarget"},{"key":"10388_CR118","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.7150\/thno.55209","volume":"11","author":"M Zhong","year":"2021","unstructured":"Zhong, M., Xiong, Y., Zhao, J., Gao, Z., Ma, J., Wu, Z., et al. (2021). Candida albicans disorder is associated with gastric carcinogenesis. Theranostics, 11, 4945\u20134956.","journal-title":"Theranostics"},{"key":"10388_CR119","doi-asserted-by":"crossref","unstructured":"Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, et al.\u00a0of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20:859\u2013867.","DOI":"10.1158\/1078-0432.CCR-13-1343"},{"key":"10388_CR120","doi-asserted-by":"crossref","unstructured":"Iftekhar A, Berger H, Bouznad N, Heuberger J, Boccellato F, Dobrindt U, et al.\u00a0Genomic aberrations after short-term exposure to colibacin-producing E. coli transform primary colon epithelial cells. Nat Commun. 2021;12:1003.","DOI":"10.1038\/s41467-021-21162-y"},{"key":"10388_CR121","doi-asserted-by":"crossref","unstructured":"Haghi F, Goli E, Mirzaei B, Zeighman H. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19:879.","DOI":"10.1186\/s12885-019-6115-1"},{"key":"10388_CR122","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.chom.2015.05.002","volume":"17","author":"T Scanu","year":"2015","unstructured":"Scanu, T., Spaapen, R. M., Bakker, J. M., Pratap, C. B., Wu, L. E., Hofland, I., et al. (2015). Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma. Cell Host & Microbe, 17, 763\u2013774.","journal-title":"Cell Host & Microbe"},{"key":"10388_CR123","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmellet","year":"2000","unstructured":"Carmellet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249\u2013257.","journal-title":"Nature"},{"issue":"6","key":"10388_CR124","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02035-14","volume":"5","author":"JD MacManiman","year":"2014","unstructured":"MacManiman, J. D., Meuser, A., Botto, S., Smith, P. P., Liu, F., Jarvis, M. A., et al. (2014). Human cytomegalovirus-encoded pUL7 is a novel CEACAM1-like molecule responsible for promotion of angiogenesis. mBio, 5(6), Article e02035.","journal-title":"mBio"},{"key":"10388_CR125","doi-asserted-by":"crossref","unstructured":"Farkuddin Md, Chowdhury Z, Alam Shibly SUIA, UI Islam SMB, Jime JS, et al.\u00a0Microbial avengers: How microorganisms drive angiogenesis for good and bad? J Angiotherapy. 2024;8(5):1\u201312.","DOI":"10.25163\/angiotherapy.859650"},{"key":"10388_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02224-5","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Bai, M., Peng, O., Li, L., Tian, F., Guo, Y., et al. (2024). Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease. European Journal of Medical Research, 29, Article 614.","journal-title":"European Journal of Medical Research"},{"key":"10388_CR127","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fimmu.2013.00445","volume":"4","author":"T Vieira","year":"2013","unstructured":"Vieira, T., Tebeira, M. M., & Martins, F. S. (2013). The role of probiotics and prebiotics in inducing gut immunity. Frontiers in Immunology, 4, 445.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10388_CR128","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00394-013-0506-x","volume":"53","author":"K Yoda","year":"2013","unstructured":"Yoda, K., Miyakawa, K., Hosoda, M., Miramatsu, M., Yan, F., & He, F. (2013). Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor. European Journal of Nutrition, 53(1), 105\u2013115.","journal-title":"European Journal of Nutrition"},{"key":"10388_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747914","volume":"12","author":"X Wan","year":"2021","unstructured":"Wan, X., Song, M., Wang, A., Zhao, Y., Wei, Z., & Lu, Y. (2021). Microbiome crosstalk in immunotherapy and antiangiogenesis therapy. Frontiers in Immunology, 12, Article 747914.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10388_CR130","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.gastro.2012.11.005","volume":"144","author":"A Schirbel","year":"2013","unstructured":"Schirbel, A., Kessler, S., Rieder, F., West, G., Rebert, N., Asosingh, K., et al. (2013). Pro-angiogenic activity of TLRs and NLRs; A novel link between gut microbiota and intestinal angiogenesis. Gastroenterology, 144(3), 613-623.e9.","journal-title":"Gastroenterology"},{"issue":"2","key":"10388_CR131","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s42770-023-00940-4","volume":"54","author":"W Malespin-Bendana","year":"2023","unstructured":"Malespin-Bendana, W., Ferreira, R. M., Pinto, M., Figueiredo, C., Alpizar-Alpizar, W., Une, C., Figueroa-Protti, L., et al. (2023). Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line. Brazilian Journal of Microbiology\u202f: [Publication of the Brazilian Society for Microbiology], 54(2), 791\u2013801.","journal-title":"Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]"},{"key":"10388_CR132","doi-asserted-by":"crossref","unstructured":"Tsukamoto K, Kumadaki K, Tatematsu K, Suzuki N, Doi Y. The Bartonella baciliformis BafA promotes endothelial cel angiogenesis via VEGFR receptor signaling pathway. mSphere. 2022;7(2):e0008122.","DOI":"10.1128\/msphere.00081-22"},{"key":"10388_CR133","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1017\/S0031182010001642","volume":"138","author":"RD Dennis","year":"2011","unstructured":"Dennis, R. D., Schubert, U., & Bauer, C. (2011). Angiogenesis and parasitic-helmint-associated neovascularization. Parasitology, 138, 426\u2013439.","journal-title":"Parasitology"},{"issue":"4","key":"10388_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005479","volume":"12","author":"N Osherov","year":"2016","unstructured":"Osherov, N., & Ben-Ami, R. (2016). Modulation of host angiogenesis as a microbial survival strategy and therapeutic target. PLoS Pathogens, 12(4), Article e1005479.","journal-title":"PLoS Pathogens"},{"issue":"4","key":"10388_CR135","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.chom.2018.09.016","volume":"24","author":"M Uusi-M\u00e4kel\u00e4","year":"2018","unstructured":"Uusi-M\u00e4kel\u00e4, M., & R\u00e4met, M. (2018). Hijacking. Host angiogenesis to drive mycobacterial growth. Cell Host & Microbe, 24(4), 465\u2013466.","journal-title":"Cell Host & Microbe"},{"issue":"24","key":"10388_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417199","volume":"24","author":"A Sevcikova","year":"2023","unstructured":"Sevcikova, A., Mladosievicova, B., Mego, M., & Ciernikova, S. (2023). Exploring the role of the gut and intratumoral microbiomes in tumor progression and metastasis. International Journal of Molecular Sciences, 24(24), Article 17199.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10388_CR137","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","volume":"163","author":"G Pinhal-Enfield","year":"2003","unstructured":"Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G. J., et al. (2003). An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. American Journal of Pathology, 163(2), 711\u201321.","journal-title":"American Journal of Pathology"},{"issue":"6","key":"10388_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061385","volume":"10","author":"W Gonciarz","year":"2021","unstructured":"Gonciarz, W., Krupa, A., Moran, A. P., Tomaszewska, A., & Chmiela, M. (2021). Interference of LPS H. pylori with IL-33-driven regeneration of Caviae porcellus primary gastric epithelial cells and fibroblasts. Cells, 10(6), Article 1385.","journal-title":"Cells"},{"issue":"6","key":"10388_CR139","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41385-022-00555-2","volume":"15","author":"HJ Lee","year":"2022","unstructured":"Lee, H. J., Yoon, C. H., Kim, H. J., Ko, J. H., Ryu, J. S., Jo, D. H., et al. (2022). Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization. Mucosal Immunology, 15(6), 1350\u20131362.","journal-title":"Mucosal Immunology"},{"issue":"3","key":"10388_CR140","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2025.36.e38","volume":"36","author":"M Okazawa-Sakai","year":"2025","unstructured":"Okazawa-Sakai, M., Sakai, S. A., Hyodo, I., Horasawa, S., Sawada, K., Fujisawa, T., et al. (2025). Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer. Journal of Gynecologic Oncology, 36(3), Article e38. https:\/\/doi.org\/10.3802\/jgo.2025.36.e38","journal-title":"Journal of Gynecologic Oncology"},{"key":"10388_CR141","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11574","volume":"9","author":"D Jacobson","year":"2021","unstructured":"Jacobson, D., Moore, K., Gunderson, C., Rowland, M., Austin, R., Honap, T. P., et al. (2021). Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer. PeerJ, 9, Article e11574. https:\/\/doi.org\/10.7717\/peerj.11574","journal-title":"PeerJ"},{"issue":"6","key":"10388_CR142","first-page":"2267","volume":"21","author":"M Englert-Golon","year":"2025","unstructured":"Englert-Golon, M., Sajdak, S., Plagens-Rotman, K. M., Merks, P., Kedzia, W., & Durda-Masny, M. (2025). Potential role of microbiota in ovarian cancer. Archives of Medical Science, 21(6), 2267\u20132273.","journal-title":"Archives of Medical Science"},{"issue":"2","key":"10388_CR143","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.taap.2008.12.009","volume":"235","author":"TF Ho","year":"2009","unstructured":"Ho, T. F., Peng, Y., Chuang, S., Lin, S. C., Feng, B., Lu, C., et al. (2009). Prodigiosin down regulates surviving to facilitate paclitaxel sensitization in human breast cancer carcinoma cell lines. Tox Appl Pharmacol., 235(2), 253\u2013260.","journal-title":"Tox Appl Pharmacol."},{"issue":"8","key":"10388_CR144","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/md19080408","volume":"19","author":"YC Chu","year":"2021","unstructured":"Chu, Y. C., Chang, C., Liao, H. R., Fu, S. L., & Chen, J. J. (2021). Anti-cancer and anti-inflammatory activities of three new chromone derivatives from marine derived Penicillum citrinum. Marine Drugs., 19(8), 408.","journal-title":"Marine Drugs."},{"issue":"3","key":"10388_CR145","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4014\/jmb.2110.10039","volume":"32","author":"JP Jang","year":"2022","unstructured":"Jang, J. P., Jang, M., Nogawa, T., Takahashi, S., Osada, H., Ahn, J. S., et al. (2022). RK-270D and E, oxindole derivatives from Streptomyces sp. with anti-angiogenic activity. Journal of Microbiology and Biotechnology, 32(3), 302\u2013306.","journal-title":"Journal of Microbiology and Biotechnology"},{"issue":"1","key":"10388_CR146","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/microorganisms12010127","volume":"12","author":"MG Hassan","year":"2024","unstructured":"Hassan, M. G., Elmezain, W. A., Baraka, D. M., AboElmaaty, S. A., Elhassanein, A., Ibrahim, R. M., et al. (2024). Anti-cancer and anti-oxidant bioactive metabolites from Aspergillus fumigatus WA7S6 Isolated from marine sources: In vitro and in silico studies. Microorganisms., 12(1), 127.","journal-title":"Microorganisms."},{"issue":"3","key":"10388_CR147","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-024-03889-0","volume":"40","author":"SB Mudaliar","year":"2024","unstructured":"Mudaliar, S. B., & Prasad, A. S. B. (2024). A biomedical perspective of pyocyanin from Pseudomonas aeruginosa:  Its applications and challenges. World Journal of Microbiology & Biotechnology, 40(3), Article 90.","journal-title":"World Journal of Microbiology & Biotechnology"},{"key":"10388_CR148","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.foodres.2019.05.002","volume":"123","author":"MSR Rajoka","year":"2019","unstructured":"Rajoka, M. S. R., Zhao, H., Mehwish, H. M., Li, N., Lu, Y., Lian, Z., et al. (2019). Anti-tumor potential of cell free culture supernatant of Lactobacillus rhamnosus strains isolated from human breast milk. Food Research International, 123, 286\u2013297.","journal-title":"Food Research International"},{"issue":"1","key":"10388_CR149","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-021-01971-3","volume":"21","author":"Z Faghfoori","year":"2021","unstructured":"Faghfoori, Z., Faghfoori, M. H., Saber, A., Izadi, A., & Yari Khosroushahi, A. (2021). Anticancer effects of bifidobacteria on colon cancer cell lines. Cancer Cell International, 21(1), 258.","journal-title":"Cancer Cell International"},{"key":"10388_CR150","first-page":"7607470","volume":"2022","author":"M Hashemi-Khah","year":"2022","unstructured":"Hashemi-Khah, M., Soleimani, N. A., Forghnifard, M. M., Gholami, O., Taheri, S., & Amoueian, S. (2022). An in vivo study on Lactobacillus rhamnosus (PTCC 1637) as a new therapeutic candidate in esophageal cancer. Bio Med Res Int., 2022, 7607470.","journal-title":"Bio Med Res Int."},{"key":"10388_CR151","doi-asserted-by":"publisher","DOI":"10.1590\/fst.87221","volume":"42","author":"R Adiyoga","year":"2022","unstructured":"Adiyoga, R., Arief, I. I., Budiman, C., & Abidin, Z. (2022). In vitro anticancer potentials of Lactobacillus plantarum IIA-1A5 and Lactobacillus acidophilus IIA-2B4 extracts against WiDr human colon cancer cell line. Food Science and Technology, 42, Article e87221.","journal-title":"Food Science and Technology"},{"issue":"3","key":"10388_CR152","doi-asserted-by":"publisher","first-page":"24","DOI":"10.20517\/mrr.2023.23","volume":"2","author":"G Procaccianti","year":"2023","unstructured":"Procaccianti, G., Roggiani, S., Conti, G., Brigidi, P., Turroni, S., & D\u2019Amico, F. (2023). Bifidobacterium in anticancer immunochemotherapy: Friend or foe? Microbiome Research Reports, 2(3), 24.","journal-title":"Microbiome Research Reports"},{"issue":"3","key":"10388_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23030563","volume":"23","author":"HN Lim","year":"2018","unstructured":"Lim, H. N., Jang, J. P., Han, J. M., Jang, J. H., Ahn, J. S., & Jung, H. J. (2018). Antiangiogenic potential of microbial metabolite elaiophylin for targeting tumor angiogenesis. Molecules, 23(3), Article 563.","journal-title":"Molecules"},{"issue":"6","key":"10388_CR154","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrd.2015.17","volume":"15","author":"N Ferrara","year":"2016","unstructured":"Ferrara, N., & Adamis, A. P. (2016). Ten years of anti-vascular endothelial growth factor therapy. Nature Reviews Drug Discovery, 15(6), 385\u2013403.","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10388_CR155","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte, R. S., Chen, D. S., & Ferrara, N. (2019). VEGF in signaling and disease: Beyond discovery and development. Cell, 176(6), 1248\u20131264.","journal-title":"Cell"},{"issue":"5","key":"10388_CR156","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain, R. K. (2014). Antiangiogenesis strategies revisited: From starving tumors to alleviating hypoxia. Cancer Cell, 26(5), 605\u2013622.","journal-title":"Cancer Cell"},{"issue":"1","key":"10388_CR157","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","volume":"65","author":"H Maeda","year":"2013","unstructured":"Maeda, H., Nakamura, H., & Fang, J. (2013). The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Advanced Drug Delivery Reviews, 65(1), 71\u201379.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"5706","key":"10388_CR158","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain, R. K. (2005). Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science, 307(5706), 58\u201362.","journal-title":"Science"},{"issue":"3","key":"10388_CR159","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel, S., Duda, D. G., Xu, L., Munn, L., Boucher, Y., Fukumura, D., & Jain, R. (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiological Reviews, 91(3), 1071\u20131121.","journal-title":"Physiological Reviews"},{"issue":"5","key":"10388_CR160","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018). Enhancing cancer immunotherapy using antiangiogenics: Opportunities and challenges. Nature Reviews Clinical Oncology, 15(5), 325\u2013340.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"1","key":"10388_CR161","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017). Cancer nanomedicine: Progress, challenges and opportunities. Nature Reviews Cancer, 17(1), 20\u201337.","journal-title":"Nature Reviews Cancer"},{"key":"10388_CR162","first-page":"737","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng, Y., Tang, Q., Wang, B., Yang, Q., Zhang, Y., Lei, L., & Li, S. (2024). Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy. Journal of Nanbiotechnology, 22, 737.","journal-title":"Journal of Nanbiotechnology"},{"key":"10388_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1148131","volume":"13","author":"D Xu","year":"2023","unstructured":"Xu, D., Luo, Y., Wang, P., Li, J., Ma, L., Huang, J., et al. (2023). Clinical progress of anti-angiogenic targeted therapy and combination therapy for gastric cancer. Frontiers in Oncology, 13, Article 1148131.","journal-title":"Frontiers in Oncology"},{"key":"10388_CR164","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3390\/jcm12093226","volume":"12","author":"I Nakayama","year":"2023","unstructured":"Nakayama, I., & Takahari, D. (2023). The role of angiogenesis targeted therapies in metastatic advanced gastric cancer. Journal of Clinical Medicine, 12, 3226.","journal-title":"Journal of Clinical Medicine"},{"key":"10388_CR165","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00228-024-03734-1","volume":"80","author":"R Ren","year":"2024","unstructured":"Ren, R., Zhang, Z., Zhai, S., et al. (2024). Efficacy and safety of ramucirumab for gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis. European Journal of Clinical Pharmacology, 80, 1697\u20131714.","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10388_CR166","doi-asserted-by":"crossref","unstructured":"Wu R, Yuan S, Wang Y, Nan Y, Chen Z, Y H, Wang Z, et al. Efficacy and safety of ramucirumab in gastric or gastroesophageal cancer: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2024;48:102466.","DOI":"10.1016\/j.clinre.2024.102466"},{"issue":"1","key":"10388_CR167","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu, Z. L., Chen, H. H., Zheng, L. L., Sun, L. P., & Shi, L. (2023). Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction and Targeted Therapy, 8(1), 198.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10388_CR168","first-page":"451","volume":"15","author":"D Basile","year":"2021","unstructured":"Basile, D., Simionato, F., Cappetta, A., Garattini, S. K., Roviello, G., & Aprile, G. (2021). State-of-the-art of monoclonal antibodies for the treatment of gastric cancer. Biologics: Targets & Therapy, 15, 451\u2013462.","journal-title":"Biologics: Targets & Therapy"},{"issue":"1","key":"10388_CR169","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s13277-015-4408-9","volume":"37","author":"G Roviello","year":"2016","unstructured":"Roviello, G., Polom, K., Petrioli, R., Marano, L., Marrelli, D., Paganini, G., et al. (2016). Monoclonal antibodies-based treatment in gastric cancer: Current status and future perspectives. Tumor Biology, 37(1), 127\u201340.","journal-title":"Tumor Biology"},{"issue":"1","key":"10388_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0340-8","volume":"9","author":"J Yu","year":"2016","unstructured":"Yu, J., Zhang, Y., Leung, L. H., Liu, L., Yang, F., & Yao, X. (2016). Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: A systematic review and meta-analysis. Journal of Hematology & Oncology, 9(1), Article 111.","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10388_CR171","first-page":"484","volume":"21","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Shen, L., & Peng, Z. (2024). Advances in MET tyrosine kinase inhibitors in gastric cancer. Cancer Biology & Medicine, 21(6), 484\u201398.","journal-title":"Cancer Biology & Medicine"},{"issue":"20","key":"10388_CR172","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.3390\/cancers17203354","volume":"17","author":"S Boichuk","year":"2025","unstructured":"Boichuk, S., & Gessel, T. (2025). Repurposing tyrosine kinase inhibitors targeting FGFR and VEGFR pathways for cancer therapy. Cancers, 17(20), 3354.","journal-title":"Cancers"},{"key":"10388_CR173","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11523-024-01067-8","volume":"19","author":"T Van Nguyen","year":"2024","unstructured":"Van Nguyen, T., Hamdan, D., Falgarone, G., et al. (2024). Anti-angiogenic tyrosine kinase inhibitor-related toxicities among cancer patients: A systematic review and meta-analysis. Targeted Oncology, 19, 533\u2013545.","journal-title":"Targeted Oncology"},{"issue":"4","key":"10388_CR174","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04729-4","volume":"80","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi, N., Fardi, E., Ghaderi, H., Palizdar, S., Khorram, R., Vafadar, R., et al. (2023). Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences, 80(4), Article 104.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"3","key":"10388_CR175","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.critrevonc.2015.07.001","volume":"96","author":"V Ricci","year":"2015","unstructured":"Ricci, V., Ronzoni, M., & Fabozzi, T. (2015). Aflibercept a new target therapy in cancer treatment: A review. Critical Reviews in Oncology\/Hematology, 96(3), 569\u2013576.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"2","key":"10388_CR176","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-013-0368-7","volume":"16","author":"KK Ciombor","year":"2014","unstructured":"Ciombor, K. K., & Berlin, J. (2014). Aflibercept\u2014A decoy VEGF receptor. Current Oncology Reports, 16(2), Article 368.","journal-title":"Current Oncology Reports"},{"key":"10388_CR177","unstructured":"Suresh B, Patel P. Aflibercept. In: StatPearls. NCBI Bookshelf, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582136\/?report=printable"},{"key":"10388_CR178","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40942-016-0026-y","volume":"2","author":"JR de Oliveira Dias","year":"2016","unstructured":"de Oliveira Dias, J. R., de Andrade, G. C., Novais, E. A., Farah, M. E., & Rodrigues, E. B. (2016). Fusion proteins for treatment of retinal diseases: Aflibercept, ziv-aflibercept, and conbercept. Int J Retina Vitreous., 2, 3.","journal-title":"Int J Retina Vitreous."},{"issue":"2","key":"10388_CR179","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/jcmm.12496","volume":"19","author":"L Qiao","year":"2015","unstructured":"Qiao, L., Liang, N., Zhang, J., Xie, J., Liu, F., Xu, D., et al. (2015). Advanced research on vasculogenic mimicry in cancer. Journal of Cellular and Molecular Medicine, 19(2), 315\u201326.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"3","key":"10388_CR180","first-page":"595","volume":"2","author":"F Pezzella","year":"2019","unstructured":"Pezzella, F. (2019). Mechanisms of resistance to anti-angiogenic treatments. Cancer Drug Resist., 2(3), 595\u2013607.","journal-title":"Cancer Drug Resist."},{"issue":"8","key":"10388_CR181","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers, G., & Hanahan, D. (2008). Modes of resistance to anti-angiogenic therapy. Nature Reviews. Cancer, 8(8), 592\u2013603.","journal-title":"Nature Reviews. Cancer"},{"issue":"7","key":"10388_CR182","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","volume":"14","author":"H Ragelle","year":"2017","unstructured":"Ragelle, H., Danhier, F., Pr\u00e9at, V., Langer, R., & Anderson, D. G. (2017). Nanoparticle-based drug delivery systems: A commercial and regulatory outlook as the field matures. Expert Opinion on Drug Delivery, 14(7), 851\u2013864.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10388_CR183","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.smaim.2020.04.001","volume":"1","author":"Y Dang","year":"2020","unstructured":"Dang, Y., & Guan, J. (2020). Nanoparticle-based drug delivery systems for cancer therapy. Smart Materials in Medicine, 1, 10\u201319.","journal-title":"Smart Materials in Medicine"},{"key":"10388_CR184","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jconrel.2019.07.033","volume":"309","author":"F Sousa","year":"2019","unstructured":"Sousa, F., Dhaliwal, H. K., Gattacceca, F., Sarmento, B., & Amiji, M. M. (2019). Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles. Journal of Controlled Release, 309, 37\u201347.","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10388_CR185","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/10717544.2020.1754528","volume":"27","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Yang, W., Ma, F., Ma, Q., Zhang, B., Zhang, Y., et al. (2020). Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis. Drug Delivery, 27(1), 691\u2013702.","journal-title":"Drug Delivery"},{"issue":"9","key":"10388_CR186","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1021\/acs.biomac.5b00907","volume":"16","author":"YH Lin","year":"2015","unstructured":"Lin, Y. H., Chen, Z. R., Lai, C. H., Hsieh, C. H., & Feng, C. L. (2015). Active targeted nanoparticles for oral administration of gastric cancer therapy. Biomacromolecules, 16(9), 3021\u201332.","journal-title":"Biomacromolecules"},{"key":"10388_CR187","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2147\/IJN.S125573","volume":"12","author":"Z Song","year":"2017","unstructured":"Song, Z., Lin, Y., Zhang, X., Feng, C., Lu, Y., Gao, Y., et al. (2017). Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: Enhanced cellular uptake and improved therapeutic effects. International Journal of Nanomedicine, 12, 1941\u20131958.","journal-title":"International Journal of Nanomedicine"},{"key":"10388_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2023.121908","volume":"382","author":"MH Tabrizi","year":"2023","unstructured":"Tabrizi, M. H., Soltani, M., & Es-haghi, A. (2023). Preparation and characterization of the farnesiferol C-loaded solid lipid nanoparticles decorated with folic acid-bound chitosan and evaluation of its in vitro anti-cancer and anti-angiogenic activities. Journal of Molecular Liquids, 382, Article 121908.","journal-title":"Journal of Molecular Liquids"},{"issue":"3","key":"10388_CR189","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/cas.13488","volume":"109","author":"H Zhang","year":"2018","unstructured":"Zhang, H., Wang, Y., Bai, M., Wang, J., Zhu, K., Liu, R., et al. (2018). Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA. Cancer Science, 109(3), 629\u2013641.","journal-title":"Cancer Science"},{"issue":"1","key":"10388_CR190","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12935-023-02985-9","volume":"23","author":"FA Abouelnazar","year":"2023","unstructured":"Abouelnazar, F. A., Zhang, X., Zhang, J., Wang, M., Yu, D., Zang, X., et al. (2023). SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4\/VEGF pathway inhibits cancer progression. Cancer Cell International, 23(1), 149.","journal-title":"Cancer Cell International"},{"key":"10388_CR191","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.biopha.2018.05.151","volume":"105","author":"S Vimalraj","year":"2018","unstructured":"Vimalraj, S., Ashokkumar, T., & Saravanan, S. (2018). Biogenic gold nanoparticles synthesis mediated by Mangifera indica seed aqueous extracts exhibits antibacterial, anticancer and anti-angiogenic properties. Biomedicine & Pharmacotherapy, 105, 440\u2013448.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10388_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsadv.2023.100372","volume":"13","author":"TP Patil","year":"2023","unstructured":"Patil, T. P., Vibhute, A. A., Patil, S. L., Dongale, T. D., & Tiwari, A. P. (2023). Green synthesis of gold nanoparticles via Capsicum annum fruit extract: Characterization, antiangiogenic, antioxidant and anti-inflammatory activities. Appl Surf Sci Adv., 13, Article 100372.","journal-title":"Appl Surf Sci Adv."},{"issue":"1","key":"10388_CR193","first-page":"7","volume":"20","author":"P Zanjanchi","year":"2022","unstructured":"Zanjanchi, P., Asghari, S. M., Mohabatkar, H., Shourian, M., & Shafiee, A. M. (2022). Conjugation of VEGFR1\/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity. Journal of Nanbiotechnology, 20(1), 7.","journal-title":"Journal of Nanbiotechnology"},{"issue":"1","key":"10388_CR194","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1038\/s41467-021-26694-x","volume":"12","author":"L Fan","year":"2021","unstructured":"Fan, L., Wang, W., Wang, Z., & Zhao, M. (2021). Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis. Nature Communications, 12(1), 6371.","journal-title":"Nature Communications"},{"key":"10388_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101400","volume":"16","author":"Z Lin","year":"2026","unstructured":"Lin, Z., Deng, Z., Liang, J., Chen, B., Huang, Y., Liu, B., & Zhao, Y. (2026). Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K\/Akt signaling pathway-mediated ferroptosis. J Pharm Anal., 16, Article 101400.","journal-title":"J Pharm Anal."},{"issue":"5","key":"10388_CR196","doi-asserted-by":"publisher","first-page":"100904","DOI":"10.1016\/j.jpha.2023.11.011","volume":"14","author":"B Chen","year":"2024","unstructured":"Chen, B., Zhao, Y., Lin, Z., Liang, J., Fan, J., Huang, Y., et al. (2024). Apatinib and gamabufotalin co-loaded lipid\/Prussian blue nanoparticles for synergistic therapy to gastric cancer with metastasis. Journal of Pharmaceutical Analysis, 14(5), 100904.","journal-title":"Journal of Pharmaceutical Analysis"},{"issue":"6","key":"10388_CR197","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1021\/acs.nanolett.1c00168","volume":"21","author":"B Li","year":"2021","unstructured":"Li, B., Chu, T., Wei, J., Zhang, Y., Qi, F., Lu, Z., et al. (2021). Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment. Nano Letters, 21(6), 2588\u20132595.","journal-title":"Nano Letters"},{"key":"10388_CR198","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.msec.2017.08.058","volume":"82","author":"R Dhivya","year":"2018","unstructured":"Dhivya, R., Ranjani, J., Rajendhran, J., Mayandi, J., & Annaraj, J. (2018). Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA\/ZnO nanoparticles. Materials Science & Engineering C, Materials for Biological Applications, 82, 182\u2013189.","journal-title":"Materials Science & Engineering C, Materials for Biological Applications"},{"issue":"11","key":"10388_CR199","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1007\/s11033-023-08797-4","volume":"50","author":"MAH Alkwedhim","year":"2023","unstructured":"Alkwedhim, M. A. H., Pouresmaeil, V., Davoodi-Dehaghani, F., Mahavar, M., & Homayouni Tabrizi, M. (2023). Synthesis and evaluation of biological effects of modified graphene oxide nanoparticles containing Lawson (Henna extract) on gastric cancer cells. Molecular Biology Reports, 50(11), 8971\u20138983.","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"10388_CR200","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12645-023-00222-6","volume":"14","author":"A Al-Janabi","year":"2023","unstructured":"Al-Janabi, A., Hayati Roodbari, N., & Homayouni, T. M. (2023). Investigating the anticancer and anti-angiogenic effects of graphene oxide nanoparticles containing 6-gingerol modified with chitosan and folate. Cancer Nanotechnol., 14(1), 69.","journal-title":"Cancer Nanotechnol."},{"issue":"28","key":"10388_CR201","doi-asserted-by":"publisher","first-page":"23353","DOI":"10.1021\/acsami.7b04971","volume":"9","author":"X Ding","year":"2017","unstructured":"Ding, X., Su, Y., Wang, C., Zhang, F., Chen, K., Wang, Y., et al. (2017). Synergistic suppression of tumor angiogenesis by the co-delivering of vascular endothelial growth factor targeted siRNA and candesartan mediated by functionalized carbon nanovectors. ACS Applied Materials & Interfaces, 9(28), 23353\u201323369.","journal-title":"ACS Applied Materials & Interfaces"},{"issue":"3","key":"10388_CR202","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris, J. M., & Chess, R. B. (2003). Effect of pegylation on pharmaceuticals. Nature Reviews. Drug Discovery, 2(3), 214\u201321.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"5","key":"10388_CR203","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","volume":"22","author":"FM Veronese","year":"2008","unstructured":"Veronese, F. M., & Mero, A. (2008). The impact of PEGylation on biological therapies. BioDrugs, 22(5), 315\u201329.","journal-title":"BioDrugs"},{"issue":"Pt A","key":"10388_CR204","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews, 99(Pt A), 28\u201351.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"12","key":"10388_CR205","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","volume":"19","author":"JJ Verhoef","year":"2014","unstructured":"Verhoef, J. J., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014). Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discovery Today, 19(12), 1945\u201352.","journal-title":"Drug Discovery Today"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10388-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10388-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10388-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:01:59Z","timestamp":1792274519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10388-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":205,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10388"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10388-1","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}